Moreover, the cases of leukaemia described in these POT1 carrier families are in accordance with more recent data about the link between POT1 PV and the higher risk of B/T-cell lymphoproliferative and myeloproliferative diseases [6]. This evidence concerns the gene POT1 and myeloproliferative disorder.